Literature DB >> 6143910

Omeprazole inhibits elimination of diazepam.

R Gugler, J C Jensen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6143910     DOI: 10.1016/s0140-6736(84)92433-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Effect of denzimol on carbamazepine and carbamazepine-10,11-epoxide concentrations in serum, liver, spleen and different brain regions of the rat: an inhibitory metabolic interaction.

Authors:  P N Patsalos; M S Alavijeh; W Brownhill; P T Lascelles
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-01       Impact factor: 3.000

Review 2.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 3.  Omeprazole. Overview and opinion.

Authors:  S Holt; C W Howden
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

Review 4.  Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.

Authors:  D McTavish; M M Buckley; R C Heel
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

5.  Potential for drug interactions involving cytochrome P450 in patients attending palliative day care centres: a multicentre audit.

Authors:  A Wilcock; J Thomas; J Frisby; M Webster; V Keeley; G Finn; K Fossey; B Wee; J Beale; M S Lennard
Journal:  Br J Clin Pharmacol       Date:  2005-09       Impact factor: 4.335

Review 6.  Clinical pharmacology of omeprazole.

Authors:  C W Howden
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

Review 7.  Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  S P Clissold; D M Campoli-Richards
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

8.  Inhibition of human liver cytochrome P-450 by omeprazole.

Authors:  J C Jensen; R Gugler
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

Review 9.  Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.

Authors:  M I Wilde; D McTavish
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.